Connie Tsai
Director, Cell & Gene Therapy Analytical Development Novartis AG
Seminars
Wednesday 2nd December 2026
Avoiding Late-stage Failure by Delivering Potency Assays That Meet Regulatory Expectations
4:40 pm
- Prioritizing early development of functional potency assays to reduce late-stage risk and rework
- Demonstrating dose response and reproducibility to supporting smoother validation and approval
- Learning from case studies to improve assay robustness and reducing variability
